Your browser doesn't support javascript.
loading
Design of a New [PSI +]-No-More Mutation in SUP35 With Strong Inhibitory Effect on the [PSI +] Prion Propagation.
Danilov, Lavrentii G; Matveenko, Andrew G; Ryzhkova, Varvara E; Belousov, Mikhail V; Poleshchuk, Olga I; Likholetova, Daria V; Sokolov, Petr A; Kasyanenko, Nina A; Kajava, Andrey V; Zhouravleva, Galina A; Bondarev, Stanislav A.
Afiliación
  • Danilov LG; Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia.
  • Matveenko AG; Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia.
  • Ryzhkova VE; Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia.
  • Belousov MV; Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia.
  • Poleshchuk OI; Laboratory for Proteomics of Supra-Organismal Systems, All-Russia Research Institute for Agricultural Microbiology (ARRIAM), St. Petersburg, Russia.
  • Likholetova DV; Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia.
  • Sokolov PA; Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg, Russia.
  • Kasyanenko NA; Department of Molecular Biophysics and Polymer Physics, St. Petersburg State University, St. Petersburg, Russia.
  • Kajava AV; Department of Molecular Biophysics and Polymer Physics, St. Petersburg State University, St. Petersburg, Russia.
  • Zhouravleva GA; Centre de Recherche en Biologie cellulaire de Montpellier (CRBM), UMR 5237 CNRS, Université Montpellier, Montpellier, France.
  • Bondarev SA; Institut de Biologie Computationnelle (IBC), Universitè Montpellier, Montpellier, France.
Front Mol Neurosci ; 12: 274, 2019.
Article en En | MEDLINE | ID: mdl-31803017
A number of [PSI +]-no-more (PNM) mutations, eliminating [PSI +] prion, were previously described in SUP35. In this study, we designed and analyzed a new PNM mutation based on the parallel in-register ß-structure of Sup35 prion fibrils suggested by the known experimental data. In such an arrangement, substitution of non-charged residues by charged ones may destabilize the fibril structure. We introduced Q33K/A34K amino acid substitutions into the Sup35 protein, corresponding allele was called sup35-M0. The mutagenized residues were chosen based on ArchCandy in silico prediction of high inhibitory effect on the amyloidogenic potential of Sup35. The experiments confirmed that Sup35-M0 leads to the elimination of [PSI +] with high efficiency. Our data suggested that the elimination of the [PSI +] prion is associated with the decreased aggregation properties of the protein. The new mutation can induce the prion with very low efficiency and is able to propagate only weak [PSI +] prion variants. We also showed that Sup35-M0 protein co-aggregates with the wild-type Sup35 in vivo. Moreover, our data confirmed the utility of the strategy of substitution of non-charged residues by charged ones to design new mutations to inhibit a prion formation.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Mol Neurosci Año: 2019 Tipo del documento: Article País de afiliación: Rusia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Mol Neurosci Año: 2019 Tipo del documento: Article País de afiliación: Rusia
...